Choriocarcinoma
Choriocarcinoma
Choriocarcinoma is a rare and aggressive form of cancer that develops in the uterus. It's often associated with a history of molar pregnancy or other gestational trophoblastic diseases. Early detection and treatment are crucial to improve survival rates.
Show Medications for Choriocarcinoma
18/05/2026
Updated: 12/06/2026
Choriocarcinoma
Choriocarcinoma is a rare and aggressive type of cancer that develops in the uterus. It is a form of gestational trophoblastic disease (GTD), which occurs when abnormal cells grow in the placenta during pregnancy.
Symptoms
- Vaginal bleeding: Abnormal uterine bleeding can be one of the first signs of choriocarcinoma. This may include heavy or prolonged menstrual periods, or bleeding between periods.
- Pelvic pain: Severe lower abdominal pain is another common symptom of this condition.
- Weight loss: Unintentional weight loss can occur due to the cancer's effect on the body.
- Fatigue: Persistent and unexplained fatigue is a symptom that should not be ignored.
- Shortness of breath: Dyspnea, or shortness of breath, can also be a sign of choriocarcinoma.
Diagnostic Tests
To diagnose choriocarcinoma, your doctor may perform the following tests:
- Beta-hCG test (Blood test): This blood test measures the level of beta-human chorionic gonadotropin (beta-hCG) in the blood. Elevated levels can indicate choriocarcinoma.
- Ultrasound: An ultrasound examination uses sound waves to create images of the uterus and detect any abnormalities.
- Biopsy (Tissue examination): A biopsy involves removing a sample of tissue from the uterus for further examination under a microscope. This is usually done after other tests have indicated the presence of cancer.
Early detection and treatment are crucial in managing choriocarcinoma effectively. If you experience any symptoms or have concerns, consult your healthcare provider promptly.
Treatment of Choriocarcinoma
Gold Standard Treatment:
The gold standard treatment for choriocarcinoma is Etoposide, a chemotherapeutic agent.
Etoposide works by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division. By blocking this enzyme, etoposide prevents cancer cells from dividing and ultimately leads to their death.
Alternative Treatments:
- Topotecan: Topotecan is another chemotherapeutic agent that can be used as an alternative treatment for choriocarcinoma. It works by inhibiting the enzyme topoisomerase I, which is also essential for DNA replication and cell division.
- Paclitaxel: Paclitaxel is a chemotherapeutic agent that can be used as an alternative treatment for choriocarcinoma. It works by stabilizing microtubules in the cell, preventing them from disassembling and ultimately leading to cell death.
- Radiation Therapy: Radiation therapy can also be used as a treatment option for choriocarcinoma. It involves using high-energy radiation to kill cancer cells or slow their growth.
Causes and Risk Factors of Choriocarcinoma
Introduction
Choriocarcinoma is a rare and aggressive form of cancer that arises from the placenta during pregnancy. Understanding its causes and risk factors is crucial for early detection and effective treatment.Risk Factors
The following are established risk factors associated with choriocarcinoma:- History of Molar Pregnancy: A previous history of gestational trophoblastic disease, particularly molar pregnancy, increases the risk of developing choriocarcinoma.
- Age Less Than 40 Years: Younger age at diagnosis is a significant risk factor for choriocarcinoma.
- Women who have never given birth before are at higher risk of developing this condition.
- Family History of Cancer: A first-degree relative with a history of cancer may increase the risk of developing choriocarcinoma.